CLAY MARVIN: Open Payments
NPI 1992397657 · UNION CITY, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$586 in 37 payments from 8 companies in 2025. Trend: 2023 $740 · 2024 $711 · 2025 $586
Food & beverage: $586
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $272 |
| Novo Nordisk Inc | 3 | $95 |
| AstraZeneca Pharmaceuticals LP | 2 | $53 |
| PFIZER INC. | 3 | $53 |
| Otsuka America Pharmaceutical, Inc. | 2 | $41 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
| Mirum Pharmaceuticals, Inc. | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $23 |
Products named: VRAYLAR, Ozempic, QULIPTA, UBRELVY, FARXIGA, NURTEC ODT, REXULTI, CAPLYTA.
Industry payments across TN — which companies pay providers there.
